Fatal agranulocytosis 4 years after discontinuation of clozapine.
Tiihonen
Jari
J
D000374:Aggression / Q000187:drug effects* / Q000523:psychology*; D000380:Agranulocytosis / Q000139:chemically induced* / Q000401:mortality; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D017809:Fatal Outcome; D006801:Humans; D008607:Intellectual Disability / Q000523:psychology*; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000139:chemically induced / Q000401:mortality; D013375:Substance Withdrawal Syndrome / Q000209:etiology*; D013997:Time Factors
D014150:Antipsychotic Agents; D003024:Clozapine